Watkins Tim
SEC insider (Form 3/4/5 filer). CIK 0002065965. CMO & Head of Development at Contineum Therapeutics, Inc. (CTNM). 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in SAN DIEGO, CA.
Companies Watkins Tim has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Officer, CMO & Head of Development
Watkins Tim
CIK: 0002065965
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Contineum Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect10.8K shares at avg. $16.02$174K - Jun 30, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect10.8K shares at avg. $4.50$49K - Mar 2, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect3.6K shares at avg. $4.50$16K - Mar 2, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect3.6K shares at avg. $15.02$54K - Jan 30, 2026CTNM
Contineum Therapeutics, Inc.
AwardDirectStock Option (right to buy)
160K shares- - Jan 28, 2026CTNM
Contineum Therapeutics, Inc.
ExerciseDirect3.6K shares at avg. $4.50$16K - Jan 28, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect2.8K shares at avg. $14.09$39K - Jan 28, 2026CTNM
Contineum Therapeutics, Inc.
SaleDirect811 shares at avg. $14.48$12K - Dec 29, 2025CTNM
Contineum Therapeutics, Inc.
SaleDirect3.6K shares at avg. $12.06$44K - Dec 29, 2025CTNM
Contineum Therapeutics, Inc.
ExerciseDirect3.6K shares at avg. $4.50$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 10,833 | $16.02 | $173,590 | Direct |
| Jun 30, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 10,833 | $4.50 | $48,749 | Direct |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 3,611 | $4.50 | $16,250 | Direct |
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 3,611 | $15.02 | $54,220 | Direct |
| Jan 30, 2026 | CTNM Contineum Therapeutics, Inc. | Award Stock Option (right to buy) | 160,000 | - | - | Direct |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | Exercise | 3,611 | $4.50 | $16,250 | Direct |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 2,800 | $14.09 | $39,441 | Direct |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | Sale | 811 | $14.48 | $11,747 | Direct |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | Sale | 3,611 | $12.06 | $43,558 | Direct |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | Exercise | 3,611 | $4.50 | $16,250 | Direct |
1-10 of 12 transactions